Use of Vasodilators in Heart Failure

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-802393-8.00041-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.

  2016cited by this paper
• Readmissions for Heart Failure in Children.

  2016cited by this paper
• Intravenous Home Inotropic Use Is Safe in Pediatric Patients Awaiting Transplantation

  2015cited by this paper
• Hospital Variation in Intravenous Inotrope Use for Patients Hospitalized With Heart Failure: Insights From Get With The Guidelines

  2014cited by this paper
• Angiotensin-neprilysin inhibition versus enalapril in heart failure.

  2014cited by this paper
• The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. [Corrected].

  2014cited by this paper
• Challenges and Opportunities in Pediatric Heart Failure and Transplantation Update on Pharmacological Heart Failure Therapies in Children Do Adult Medications Work in Children and if Not, Why Not?

  2014cited by this paper
• Impact of Empiric Nesiritide or Milrinone Infusion on Early Postoperative Recovery After Fontan Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

  2014cited by this paper
• Effect of Valsartan on Systemic Right Ventricular Function: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial

  2013cited by this paper
• Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines.

  2013cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

  2013cited by this paper
• Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

  2013cited by this paper
• Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.

  2013cited by this paper
• Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects

  2013cited by this paper
• Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

  2013cited by this paper
• Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*

  2012cited by this paper
• Variation in perioperative care across centers for infants undergoing the Norwood procedure.

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial

  2012cited by this paper
• Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study

  2012cited by this paper
• Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot).

  2012cited by this paper
• Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS-Paed survey

  2011cited by this paper
• Congenital Cardiac Surgery : A Randomized , Double-Blind Clinical Trial

  2011cited by this paper
• Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS‐Paed

  2011cited by this paper
• Effect of nesiritide in patients with acute decompensated heart failure.

  2011cited by this paper
• Acute effects of the ACE inhibitor enalaprilat on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection

  2011cited by this paper
• Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias.

  2011cited by this paper
• The current and future management of acute heart failure syndromes.

  2010cited by this paper
• Cardiovascular effects of relaxin: from basic science to clinical therapy

  2010cited by this paper
• Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

  2010cited by this paper
• National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities.

  2010cited by this paper
• Enalapril in Infants With Single Ventricle: Results of a Multicenter Randomized Trial

  2010cited by this paper
• The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.

  2010cited by this paper
• Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

  2009cited by this paper
• Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β‐blockers in SURVIVE †

  2009cited by this paper
• Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome?*

  2008cited by this paper
• Perioperative course in 118 infants and children undergoing coarctation repair via a thoracotomy: a prospective, multicenter experience.

  2008cited by this paper
• Ventricular-vascular interaction in heart failure.

  2008cited by this paper
• Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise.

  2008cited by this paper
• Nesiritide Improves Hemodynamics in Children with Dilated Cardiomyopathy: A Pilot Study

  2008cited by this paper
• Use of mathematic modeling to compare and predict hemodynamic effects of the modified Blalock-Taussig and right ventricle-pulmonary artery shunts for hypoplastic left heart syndrome.

  2008cited by this paper
• Sodium nitroprusside for advanced low-output heart failure.

  2008cited by this paper
• Response to Letters Regarding Article, “Comparison of the Profiles of Postoperative Systemic Hemodynamics and Oxygen Transport in Neonates After the Hybrid or the Norwood Procedure: A Pilot Study”

  2008cited by this paper
• Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure.

  2007cited by this paper
• Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

  2007cited by this paper
• Hypoplastic left heart syndrome: consensus and controversies in 2007

  2007cited by this paper
• Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass

  2007cited by this paper
• Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.

  2007cited by this paper
• Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

  2007cited by this paper
• Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

  2007cited by this paper
• Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome.

  2007cited by this paper
• Perioperative Effects and Safety of Nesiritide Following Cardiac Surgery in Children

  2006cited by this paper
• A Prospective Evaluation of Nesiritide in the Treatment of Pediatric Heart Failure

  2006cited by this paper
• Population Pharmacokinetics of Milrinone in Neonates with Hypoplastic Left Heart Syndrome Undergoing Stage I Reconstruction

  2006cited by this paper
• Ventriculo-arterial coupling: Concepts, assumptions, and applications

  2006cited by this paper
• Nesiritide in infants and children with congestive heart failure*

  2005cited by this paper
• Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial

  2005cited by this paper
• Captopril in children with dilated cardiomyopathy: Acute and long-term effects in a prospective study of hemodynamic and hormonal effects

  2005cited by this paper
• Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children.

  2005cited by this paper
• In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

  2005cited by this paper
• Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.

  2005cited by this paper
• Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery.

  2005cited by this paper
• Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy

  2005cited by this paper
• Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

  2004cited by this paper
• Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery

  2004cited by this paper
• Nesiritide use in pediatric patients with congestive heart failure.

  2004cited by this paper
• From Other Journals

  2004cited by this paper
• Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.

  2004cited by this paper
• Prevention of Early Sudden Circulatory Collapse After the Norwood Operation

  2004cited by this paper
• Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• Sustained Hemodynamic Effects of Intravenous Levosimendan

  2003cited by this paper
• Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.

  2003cited by this paper
• Relaxin, a Pregnancy Hormone, Is a Functional Endothelin-1 Antagonist: Attenuation of Endothelin-1–Mediated Vasoconstriction by Stimulation of Endothelin Type-B Receptor Expression via ERK-1/2 and Nuclear Factor-&kgr;B

  2003cited by this paper
• Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

  2002cited by this paper
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

  2002cited by this paper
• Afterload Reduction Therapy in Patients Following Intraatrial Baffle Operation for Transposition of the Great Arteries

  2002cited by this paper
• Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure.

  2002cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial

  2002cited by this paper
• Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration

  2000cited by this paper
• Inotropes in the beta‐blocker era

  2000cited by this paper
• Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

  2000cited by this paper
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure.

  1999cited by this paper
• The pharmacokinetics of milrinone in pediatric patients after cardiac surgery.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.

  1998cited by this paper
• Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture.

  1998cited by this paper
• Pharmacokinetics and Side Effects of Milrinone in Infants and Children After Open Heart Surgery

  1998cited by this paper
• Estimation of oxygen delivery in newborns with a univentricular circulation.

  1998cited by this paper
• Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.

  1997cited by this paper
• Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.

  1997cited by this paper
• Enalapril does not enhance exercise capacity in patients after Fontan procedure.

  1997cited by this paper

• No citing papers are available for this paper.